And many of us approached the two with an equally odd combination of fear, skepticism and desire. There is nothing wrong with that. It beats the alternative. Antiretroviral therapies may have reached the end of their rope. What is needed is novel thinking.
Pharmaceutical companies are happy to supply antiviral drugs.
But I don't doubt that at the end of the day they too must think about the loved ones they have lost. The challenge is for everyone. It is up to us to determine which one of them will ultimately rise.